Reconnecting

The current page stays visible while onset.to reconnects in the background.

Psychedelics improve mental health, cognition in special ops veterans: ibogaine plus 5-MeO-DMT chart review reports symptom reductions

Open original

Ibogaine hydrochloride plus 5‑MeO‑DMT therapy is linked to improved mental health and cognitive functioning in U.S. special operations forces veterans seeking care at a Mexico clinic. A chart-review analysis reported reductions in depression, anxiety, and PTSD symptoms, along with improvements in insomnia severity and anger from pre-treatment to one-month follow-up, with benefits extending through three and six months. Researchers also highlighted cognitive impairment related to traumatic brain injury as a notable area of improvement. The veterans received a single oral ibogaine hydrochloride dose and, on a separate day, incremental inhalation doses of 5‑MeO‑DMT totaling 50 mg, preceded and followed by preparation and reflection sessions. The work is positioned as supportive evidence for further testing of psychedelic-assisted therapies, including for complex trauma histories, particularly given limited response to traditional therapies for this population.